Remedy Robotics Raises $62M Series B to Advance AI Cardiovascular Care
AI-generated summary Remedy Robotics announced on November 16, 2026 that it raised $62 million in Series B funding to advance its AI-enabled robotic platform called N1 for cardiovascular procedures. DCVC led the funding round, which included participation from new investors such as UC Investments, Skip Capital, and Hostplus.